You are here

Article info

Article menu
Clinical/translational cancer immunotherapy
Original research
Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade

Authors

  • Lijun Xu Laboratory of Molecular Medicine, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, ChinaCollege of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, Henan, China PubMed articlesGoogle scholar articles
  • Bingyu Li College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, Henan, China PubMed articlesGoogle scholar articles
  • Chenyu Pi Laboratory of Molecular Medicine, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China PubMed articlesGoogle scholar articles
  • Zhaohua Zhu Laboratory of Molecular Medicine, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China PubMed articlesGoogle scholar articles
  • Fei Tao Laboratory of Molecular Medicine, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China PubMed articlesGoogle scholar articles
  • Kun Xie Laboratory of Molecular Medicine, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China PubMed articlesGoogle scholar articles
  • Yan Feng Laboratory of Molecular Medicine, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China PubMed articlesGoogle scholar articles
  • Xiaoqing Xu Laboratory of Molecular Medicine, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China PubMed articlesGoogle scholar articles
  • Yanxin Yin Tongji University Suzhou Institute, Suzhou, Jiangsu, China PubMed articlesGoogle scholar articles
  • Hua Gu Laboratory of Molecular Medicine, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China PubMed articlesGoogle scholar articles
  • Jianmin Fang Laboratory of Molecular Medicine, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, ChinaTongji Hospital Affiliated to Tongji University, Shanghai, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Jianmin Fang; jfang{at}tongji.edu.cn; Dr Hua Gu; gu_hua{at}tongji.edu.cn
View Full Text

Citation

Xu L, Li B, Pi C, et al
Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade
Journal for ImmunoTherapy of Cancer 2022;10:e005447. doi: 10.1136/jitc-2022-005447

Publication history

  • Accepted November 3, 2022
  • First published December 2, 2022.
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.